AbCellera Biologics Inc. - Common Shares (NQ:ABCL)
2.060
-0.030
(-1.44%)
Streaming Delayed Price
Updated: 12:18 PM EDT, Apr 4, 2025
Add to My Watchlist
All News about AbCellera Biologics Inc. - Common Shares

4 Analysts Have This to Say About AbCellera Biologics
February 28, 2023
Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
February 28, 2023
Via Benzinga



Preview: AbCellera Biologics's Earnings
February 20, 2023
Via Benzinga
The Latest Analyst Ratings for AbCellera Biologics
January 06, 2023
Via Benzinga

AbCellera Reports Full Year 2022 Business Results
February 21, 2023
Via Business Wire



Via Business Wire




Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga

AbCellera and AbbVie Partner to Advance New Antibody Therapies
December 15, 2022
Via Business Wire






Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Via Benzinga







AbCellera Reports Q3 2022 Business Results
November 08, 2022
Via Business Wire

AbCellera to Present at Upcoming Investor Conferences in November
November 04, 2022
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free